CRISPR Therapeutics (CRSP) was Smart Insider's stock pick of the week after the company's non-executive Simeon George bought 989,812 shares for $51.5 million on July 16 at $52.03 apiece, while "more than doubling" his stake.
George bought the shares on behalf of SR One Capital Management, where he is the managing partner, Smart Insider said in a Tuesday note.
Their only prior transactions were subscriptions for $931,000 in October 2016 and $75 million in February last year, the note added.
"We are also surprised to see the purchase, assuming the company is in a closed period with their results expected around the 10th of August," according to the note.
Smart Insider ranked the stock +N, or notable & positive signal, on July 18.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。